Europe — EMA
Campto (Irinotecan Hydrochloride Trihydrate)
Campto (Irinotecan Hydrochloride Trihydrate) is an intravenous medication used in cancer treatment. Learn about its uses, effects, and precautions.
Request sourcing
What is Irinotecan Hydrochloride Trihydrate?
Campto (Irinotecan Hydrochloride Trihydrate) is an intravenous medication used in cancer treatment. Learn about its uses, effects, and precautions.
What is Irinotecan Hydrochloride Trihydrate used for?
Campto is primarily used in the treatment of various types of cancer. It is often prescribed for colorectal cancer and other solid tumors. The medication works by interfering with the growth of cancer cells, helping to slow or stop their proliferation. Patients and healthcare providers often explore 'what is Campto used for' to understand its role in cancer therapy.
What are the side effects of Irinotecan Hydrochloride Trihydrate?
Common effects of Campto may include nausea, vomiting, diarrhea, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary widely among individuals and should be discussed with a healthcare provider.
What precautions apply to Irinotecan Hydrochloride Trihydrate?
Campto should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be monitored regularly for any adverse reactions or side effects.
What does Irinotecan Hydrochloride Trihydrate interact with?
Campto may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of Campto.



